Drugs in Development for Malaria Elizabeth A. AshleyAung Pyae Phyo Leading Article Open access 25 May 2018 Pages: 861 - 879
Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab Pratima Chowdary Leading Article Open access 29 May 2018 Pages: 881 - 890
Correction to: Inhibition of Tissue Factor Pathway Inhibitor (TFPI) as a Treatment for Haemophilia: Rationale with Focus on Concizumab Pratima Chowdary Correction 11 June 2018 Pages: 891 - 891
Targeting EGFR in Lung Cancer: Current Standards and Developments Asunción Díaz-SerranoPablo GellaLuis Paz-Ares Rodríguez Review Article 18 June 2018 Pages: 893 - 911
CGRP and Migraine: The Role of Blocking Calcitonin Gene-Related Peptide Ligand and Receptor in the Management of Migraine Kasra MaasumiRebecca L. MichaelAlan M. Rapoport Review Article 04 June 2018 Pages: 913 - 928
Sarilumab: A Review in Moderate to Severe Rheumatoid Arthritis Yvette N. LambEmma D. Deeks Adis Drug Evaluation 09 June 2018 Pages: 929 - 940
Telotristat Ethyl: A Review in Carcinoid Syndrome Diarrhoea Katherine A. Lyseng-Williamson Adis Drug Evaluation 12 June 2018 Pages: 941 - 950
Regorafenib: A Review in Hepatocellular Carcinoma Young-A. HeoYahiya Y. Syed Adis Drug Evaluation 18 June 2018 Pages: 951 - 958